82.900
−0,24%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.7% | +14.2% | 3 / 3 | +12.0% | +1.80 pp | -0.11 pp | +31.7% | 0.07 | 9.96 | 439 | +12,0% | 140 | +11,7% | 9.96 | 13.40 | −25,7% |
| Pts | 0 | 0 | 12 | 4 | 8 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 82.900 (close price on 2026-10-19)EPS (TTM): 8.323
Financial charts
1.Revenue & growth
VND bn439Q2/26
1.Revenue & growth
VND bn439Q2/26
2.Profit & growth
VND bn140Q2/26
3.Profit mix (Penman)
VND bn578Q2/26
4.Margins & cost structure
%38.3%Q2/26
5.Returns & cash cycle
% · days77.6%Q2/26
6.Earnings quality & cash
VND bn360Q2/26
7.Asset structure
VND bn2.010Q2/26
8.Funding & debt health
VND bn · times2.010Q2/26
9.Revenue backlog
VND bn3,53Q2/26
10.Valuation
times · %10,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.521Q2/26
Adjusted EPS growth, latest quarter
-25.6%
Average adjusted EPS growth, 3 quarters
1.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
50.0%
Source: vnstockData through Q2/26